Effect of TongXie-YaoFang on Cl− and HCO3- Transport in Diarrhea-Predominant Irritable Bowel Syndrome Rats

Effect of TongXie-YaoFang on Cl− and HCO3- Transport in Diarrhea-Predominant Irritable Bowel Syndrome Rats

TongXie-YaoFang (TXYF) can effectively alleviate the symptoms of diarrhea-predominant irritable bowel syndrome (D-IBS) patients. However, the curative mechanism has not been fully clarified. The study was designed to investigate the effect of TXYF on the colonic ion transport induced by serotonin (5...

Full description

Bibliographic Details
Main Authors:	Xiaofang Lu, Shengsheng Zhang, Cheng Yang, Zhengfang Wang, Luqing Zhao, Zhenyu Wu, Jing Xie
Format:	Article
Language:	English
Published:	Hindawi Limited 2016-01-01
Series:	Evidence-Based Complementary and Alternative Medicine
Online Access:	http://dx.doi.org/10.1155/2016/7954982

Similar Items

Tong-Xie-Yao-Fang Regulates 5-HT Level in Diarrhea Predominant Irritable Bowel Syndrome Through Gut Microbiota Modulation
by: Junchen Li, et al.
Published: (2018-09-01)

Efficacy and safety of Modified Tongxie Yaofang in diarrhea-predominant irritable bowel syndrome management: A meta-analysis of randomized, positive medicine-controlled trials.
by: Yun-Kai Dai, et al.
Published: (2018-01-01)

Efficacy of Tong-Xie-Yao-Fang granule and its impact on whole transcriptome profiling in diarrhea-predominant irritable bowel syndrome patients: study protocol for a randomized controlled trial
by: Yan Wang, et al.
Published: (2020-11-01)

The Effect of Tong-Xie-Yao-Fang on Intestinal Mucosal Mast Cells in Postinfectious Irritable Bowel Syndrome Rats
by: Xiangxue Ma, et al.
Published: (2017-01-01)

Tong-Xie-Yao-Fang improves intestinal permeability in diarrhoea-predominant irritable bowel syndrome rats by inhibiting the NF-κB and notch signalling pathways
by: Qiuke Hou, et al.
Published: (2019-11-01)

Network Pharmacology Identifies the Mechanisms of Action of Tongxie Anchang Decoction in the Treatment of Irritable Bowel Syndrome with Diarrhea Predominant
by: Xiang Tan, et al.
Published: (2020-01-01)

Tong Xie Yao Fang: A Classic Chinese Medicine Prescription with Potential for the Treatment of Ulcerative Colitis
by: Kai Chen, et al.
Published: (2021-01-01)

Mechanism by Which Tong Xie Yao Fang Heals the Intestinal Mucosa of Rats with Ulcerative Colitis through the Hippo Pathway
by: Wenli You, et al.
Published: (2021-01-01)

Tongxie Anchang Decoction Relieves Visceral Hypersensitivity in Diarrhea-Predominant Irritable Bowel Syndrome Rats by Regulating the NGF/TrkA Signaling Pathway
by: Xiang Tan, et al.
Published: (2021-01-01)

The study of evaluation of efficacy for the Tong Shieh Iau Fang on the diarrhea type of Irritable bowel syndrome.
by: Yuh-Ren Her, et al.
Published: (1993)

Efficacy of Compound Herbal Medicine Tong-Xie-Yao-Fang for Acute Radiation Enteritis and Its Potential Mechanisms: Evidence from Transcriptome Analysis
by: Cheng Yang, et al.
Published: (2020-01-01)

Targeted therapies for diarrhea-predominant irritable bowel syndrome
by: Olden KW
Published: (2012-05-01)

Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome
by: Lacy BE
Published: (2016-02-01)

Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
by: Özdener AE, et al.
Published: (2017-09-01)

The Study for Taiwanese Poetry of Yao-Chian Fang
by: Pei-Ju Chen, et al.
Published: (2008)

Studies on Shih-Ching Fang Pei-Chi-Chien-Chin-Yao-Fang
by: XIE, YUN-ZHONG, et al.
Published: (1992)

Study for the gynecological thoughts on gian jin yao fang
by: CHEN, JIAN-LIN, et al.
Published: (1992)

The Research of “Hui Tu Tong Yao Da Guan”
by: Li-Ling Cheng, et al.
Published: (2015)

Characterization of kynurenine pathway in patients with diarrhea-predominant irritable bowel syndrome
by: Pingping Li, et al.
Published: (2020-06-01)

TREATMENT OF DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME WITH MESALAZINE AND/OR SACCHAROMYCES BOULARDII
by: Mauro BAFUTTO, et al.
Published: (2013-12-01)

Fecal Microbiota Alterations Associated With Diarrhea-Predominant Irritable Bowel Syndrome
by: Xiaojun Zhuang, et al.
Published: (2018-07-01)

Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome: The SEPD perspective
by: Isabel Vera, et al.

Clinical potential of eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
by: Sobolewska-Włodarczyk A, et al.
Published: (2016-05-01)

The effect of bismuth subcitrate in patients with diarrhea predominant irritable bowel syndrome
by: Kalani M, et al.
Published: (2010-09-01)

Is microscopic colitis a missed diagnosis in diarrhea-predominant Irritable Bowel Syndrome?
by: Hamid Tavakoli, et al.
Published: (2008-08-01)

Serum-derived bovine immunoglobulin for children with diarrhea-predominant irritable bowel syndrome
by: Arrouk R, et al.
Published: (2018-10-01)

Gut microbiota composition and functional prediction in diarrhea-predominant irritable bowel syndrome
by: Lijun Mei, et al.
Published: (2021-03-01)

Acupuncture for Adults with Diarrhea-Predominant Irritable Bowel Syndrome or Functional Diarrhea: A Systematic Review and Meta-Analysis
by: Jianbo Guo, et al.
Published: (2020-01-01)

Epidemiology of functional diarrhea and comparison with diarrhea-predominant irritable bowel syndrome: a population-based survey in China.
by: Yan-Fang Zhao, et al.
Published: (2012-01-01)

Efficacy and Safety of Acupoint Catgut Embedding for Diarrhea-Predominant Irritable Bowel Syndrome and Constipation-Predominant Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis
by: Jing Wu, et al.
Published: (2020-01-01)

Review: Optimizing outcomes with alosetron hydrochloride in severe diarrhea-predominant irritable bowel syndrome
by: Susan L. Lucak MD
Published: (2010-05-01)

Capsule Endoscopy in Refractory Diarrhea-Predominant Irritable Bowel Syndrome and Functional Abdominal Pain
by: Manuel Valero, et al.
Published: (2018-11-01)

Asimadoline and its potential for the treatment of diarrhea-predominant irritable bowel syndrome: a review
by: Mangel AW, et al.
Published: (2012-01-01)

Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome
by: Carroll Ian M, et al.
Published: (2010-12-01)

Long-term efficacy and safety of ramosetron in the treatment of diarrhea-predominant irritable bowel syndrome
by: Chiba T, et al.
Published: (2013-07-01)

Development and validation of a biomarker for diarrhea-predominant irritable bowel syndrome in human subjects.
by: Mark Pimentel, et al.
Published: (2015-01-01)

Efficacy of Yang Xie Yi Fu Fang in recalcitrant Atopic Dermatitis
by: Cheng , hue - man, et al.
Published: (2002)

Fang Yizhi’s Life Philosophy by giving example of “Yao-Di-Pao-Zhuang”
by: Hao-ChingHo, et al.
Published: (2016)

Synthetic research in the division of 《Da ming tong wen ji ju yao》
by: Nien-Hua Hsieh, et al.
Published: (2011)

Mucosal Tuft Cell Density Is Increased in Diarrhea-Predominant Irritable Bowel Syndrome Colonic Biopsies
by: Jessica Aigbologa, et al.
Published: (2020-05-01)